Jaume Capdevila (J Capdevila)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Topics

Combination Therapy

Neuroendocrine Tumors

Top Venues

Annals of surgery

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

This page only lists publications with an associated author ORCID identifier.

Publications

Esmée A Dijkstra, Per J Nilsson, Geke A P Hospers, Renu R Bahadoer, Elma Meershoek-Klein Kranenbarg, Annet G H Roodvoets, Hein Putter, Åke Berglund, Andrés Cervantes, Rogier M P H Crolla, Marieke H J van den Beuken-van Everdingen, Jaume Capdevila, Ibrahim Edhemovic, Corrie A M Marijnen, Cornelis J H van de Velde, Bengt Glimelius, Boudewijn van Etten, null null
Locoregional Failure During and After Short-course Radiotherapy followed by Chemotherapy and Surgery Compared to Long-course Chemoradiotherapy and Surgery - A Five-year Follow-up of the RAPIDO Trial. Annals of surgery (2023)
Esmée A Dijkstra, Per J Nilsson, Geke A P Hospers, Renu R Bahadoer, Elma Meershoek-Klein Kranenbarg, Annet G H Roodvoets, Hein Putter, Åke Berglund, Andrés Cervantes, Rogier M P H Crolla, Marieke H J van den Beuken-van Everdingen, Jaume Capdevila, Ibrahim Edhemovic, Corrie A M Marijnen, Cornelis J H van de Velde, Bengt Glimelius, Boudewijn van Etten, null null
Locoregional Failure During and After Short-course Radiotherapy followed by Chemotherapy and Surgery Compared to Long-course Chemoradiotherapy and Surgery - A Five-year Follow-up of the RAPIDO Trial. Annals of surgery (2023)
Antoine Hollebecque, Stefania Salvagni, Ruth Plummer, Patricia Niccoli, Jaume Capdevila, Curigliano Giuseppe, Victor Moreno, Filippo de Braud, Sonia Gonzalez de Villambrosia, Patricia Martin-Romano, Eric Baudin, Marina Arias, Juan de Alvaro, Josep L Parra-Palau, Tania Sánchez-Pérez, Ida Aronchik, Ellen H Filvaroff, Manisha Lamba, Zariana Nikolova, Johann S de Bono
Clinical activity of CC-90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies. Cancer 128 (17) (2022)
Jaume Capdevila, Nicola Fazio, Carlos Lopez, Alexandre Teulé, Juan W Valle, Salvatore Tafuto, Ana Custodio, Nicholas Reed, Markus Raderer, Enrique Grande, Rocio Garcia-Carbonero, Paula Jiménez-Fonseca, Jorge Hernando, Alberto Bongiovanni, Francesca Spada, Vicente Alonso, Lorenzo Antonuzzo, Andrea Spallanzani, Alfredo Berruti, Adelaida La Casta, Isabel Sevilla, Patrizia Kump, Dario Giuffrida, Xavier Merino, Lorena Trejo, Pablo Gajate, Ignacio Matos, Angela Lamarca, Toni Ibrahim
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509). Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (20) (2021)
Jaime Feliú-Batlle, Rocio Garcia-Carbonero, Jaume Capdevila, Inmaculada Guasch, Vicente Alonso-Orduna, Carlos Lopez, Pilar Garcia-Alfonso, Carmen Castanon, Isabel Sevilla, Laura Cerezo, Carles Conill, Begona Quintana-Angel, Maria E Sanchez, Ismael Ghanem, Marta Martin-Richard, Miriam Lopez-Gomez, Ana Leon, Monica Caro, Teresa Fernandez, Joan Maurel
VITAL phase 2 study: Upfront 5-fluorouracil, mitomycin-C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09-02). Cancer medicine 9 (3) (2019)
Fabiola Amair-Pinedo, Ignacio Matos, Tamara Saurí, Jorge Hernando, Jaume Capdevila
The Treatment Landscape and New Opportunities of Molecular Targeted Therapies in Gastroenteropancreatic Neuroendocrine Tumors. Targeted oncology 12 (6) (2018)
X Merino-Casabiel, J Aller, J Arbizu, R García-Figueiras, C González, E Grande, P Jiménez-Fonseca, M I Sevilla, Jaume Capdevila
Consensus document on the progression and treatment response criteria in gastroenteropancreatic neuroendocrine tumors. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20 (12) (2018)